133 Publications (Page 1 of 6)
2020
Expression of circulating miR375 and miR371 to differentiate teratoma and viable germ cell tumor in patients with post-chemotherapy residual disease
Nappi, LuciaNappi, LuciaNappi, LuciaThi, MarisaThi, MarisaThi, MarisaAdra, NabilAdra, NabilAdra, NabilLeao, Ricardo Romao NazarioLeao, Ricardo Romao NazarioLeao, Ricardo Romao NazarioEigl, Bernhard JEigl, Bernhard JEigl, Bernhard JChi, Kim NChi, Kim NChi, Kim NGleave, MartinGleave, MartinGleave, MartinSo, AlanSo, AlanSo, AlanBlack, Peter CBlack, Peter CBlack, Peter CHamilton, Robert JamesHamilton, Robert JamesHamilton, Robert JamesDaneshmand, SiamakDaneshmand, SiamakDaneshmand, SiamakCary, ClintCary, ClintCary, ClintMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HNichols, Craig RNichols, Craig RNichols, Craig RKollmannsberger, Christian KKollmannsberger, Christian K and Kollmannsberger, Christian K
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 414, 2020-02-20. | Journal Article
 
Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?
Calaway, Adam CCalaway, Adam CFoster, Richard SFoster, Richard STong, YanTong, YanMasterson, Timothy AMasterson, Timothy ABihrle, RichardBihrle, RichardCary, Clint and Cary, Clint
Urologic Oncology: Seminars and Original Investigations, vol. 38, (no. 4), pp. 312, April 2020. | Journal Article
 
Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy
Douglawi, AntoinDouglawi, AntoinDouglawi, AntoinDouglawi, AntoinCalaway, AdamCalaway, AdamCalaway, AdamCalaway, AdamTachibana, IsamuTachibana, IsamuTachibana, IsamuTachibana, IsamuPanizzutti Barboza, MarceloPanizzutti Barboza, MarceloPanizzutti Barboza, MarceloPanizzutti Barboza, MarceloSpeir, RyanSpeir, RyanSpeir, RyanSpeir, RyanMasterson, TimothyMasterson, TimothyMasterson, TimothyMasterson, TimothyAdra, NabilAdra, NabilAdra, NabilAdra, NabilFoster, RichardFoster, RichardFoster, RichardFoster, RichardEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceCary, ClintCary, ClintCary, Clint and Cary, Clint
The Journal of urology, pp. 101097JU0000000000000792, 2020-Jan-31. | Journal Article
 
MP49-18 EARLY COMPLICATIONS AS A RESULT OF INDIANA POUCH URINARY DIVERSION
Speir, RyanSpeir, RyanSpeir, RyanSpeir, RyanNagle, RamzyNagle, RamzyNagle, RamzyNagle, RamzyJarvis, HannahJarvis, HannahJarvis, HannahJarvis, HannahKern, SeanKern, SeanKern, SeanKern, SeanCary, ClintCary, ClintCary, ClintCary, ClintMasterson, TimothyMasterson, TimothyMasterson, TimothyMasterson, TimothyGardner, ThomasGardner, ThomasGardner, ThomasGardner, ThomasBihrle, RichardBihrle, RichardBihrle, RichardBihrle, RichardKoch, MichaelKoch, MichaelKoch, MichaelKoch, MichaelKaimakliotis, HristosKaimakliotis, HristosKaimakliotis, Hristos and Kaimakliotis, Hristos
The Journal of Urology, vol. 203, pp. e749, 2020-04-00. | Journal Article
 
PD19-02 OUTCOMES FOLLOWING RETROPERITONEAL LYMPH NODE DISSECTION FOR CLINICAL STAGE II PATIENTS EXPERIENCING A LATE RELAPSE FOLLOWING UPFRONT PLATINUM BASED CHEMOTHERAPY
Speir, RyanSpeir, RyanKern, SeanKern, SeanMasterson, TimothyMasterson, TimothyFoster, RichardFoster, RichardCary, Clint and Cary, Clint
The Journal of Urology, vol. 203, pp. e383, 2020-04-00. | Journal Article
 
PD19-05 DOES PERCENTAGE OF SEMINOMA AT ORCHIECTOMY IMPACT PATIENT MORBIDITY AND PATHOLOGIC OUTCOMES AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR MIXED GERM CELL TUMOR?
Kern, SeanKern, SeanKern, SeanSpeir, RyanSpeir, RyanSpeir, RyanFoster, RichardFoster, RichardFoster, RichardEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceCary, ClintCary, ClintCary, ClintMasterson, TimothyMasterson, Timothy and Masterson, Timothy
The Journal of Urology, vol. 203, pp. e384, 2020-04-00. | Journal Article
 
PD60-02 LONGITUDINAL HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY
Kern, SeanKern, SeanKern, SeanSpeir, RyanSpeir, RyanSpeir, RyanKaimakliotis, HristosKaimakliotis, HristosKaimakliotis, HristosFoster, RichardFoster, RichardFoster, RichardMasterson, TimothyMasterson, TimothyMasterson, TimothyCary, ClintCary, Clint and Cary, Clint
The Journal of Urology, vol. 203, pp. e1273, 2020-04-00. | Journal Article
 
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
Taza, FadiTaza, FadiTaza, FadiTaza, FadiTaza, FadiTaza, FadiChovanec, MichalChovanec, MichalChovanec, MichalChovanec, MichalChovanec, MichalChovanec, MichalSnavely, AnnaSnavely, AnnaSnavely, AnnaSnavely, AnnaSnavely, AnnaSnavely, AnnaHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AFoster, Richard SFoster, Richard SFoster, Richard SFoster, Richard SFoster, Richard SFoster, Richard SEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAdra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, Nabil and Adra, Nabil
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, (no. 12), pp. 1345, 2020-Apr-20. | Journal Article
 
Robotic and open partial nephrectomy for tumors in a solitary kidney
Abedali, Zain AAbedali, Zain AAbedali, Zain AAbedali, Zain AAbedali, Zain AMonn, M FrancescaMonn, M FrancescaMonn, M FrancescaMonn, M FrancescaMonn, M FrancescaCleveland, Brent ECleveland, Brent ECleveland, Brent ECleveland, Brent ECleveland, Brent ESulek, JaySulek, JaySulek, JaySulek, JaySulek, JayBahler, Clinton DBahler, Clinton DBahler, Clinton DBahler, Clinton DBahler, Clinton DKoch, Michael OKoch, Michael OKoch, Michael OKoch, Michael OKoch, Michael OBihrle, RichardBihrle, RichardBihrle, RichardBihrle, RichardBihrle, RichardMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AGardner, Thomas AGardner, Thomas AGardner, Thomas AGardner, Thomas AGardner, Thomas ABoris, Ronald SBoris, Ronald SBoris, Ronald SBoris, Ronald SBoris, Ronald SSundaram, Chandru PSundaram, Chandru PSundaram, Chandru PSundaram, Chandru P and Sundaram, Chandru P
Journal of Clinical Urology, pp. 205141581989047, 2020-01-20. | Journal Article
 
Surgical salvage in patients with advanced testicular cancer: indications, risks and outcomes
Speir, Ryan WCary, Clint and Masterson, Timothy A
Translational andrology and urology, vol. 9, (no. Suppl 1), pp. S90, 2020-Jan. | Journal Article
2019
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer
Calaway, Adam CCalaway, Adam CCalaway, Adam CEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AFoster, Richard SFoster, Richard SFoster, Richard SCary, ClintCary, Clint and Cary, Clint
European Urology, vol. 76, (no. 5), pp. 609, November 2019. | Journal Article
 
Complications of Retroperitoneal Lymph Node Dissection
Cary, ClintCary, ClintFoster, Richard SFoster, Richard SMasterson, Timothy A and Masterson, Timothy A
Urologic Clinics of North America, vol. 46, (no. 3), pp. 437, August 2019. | Journal Article
 
Current controversies on the role of lymphadenectomy for testicular cancer for the journal: Urologic Oncology: Seminars and Original Investigations for the special seminars section on the role of lymphadenectomy for urologic cancers
Masterson, Timothy AMasterson, Timothy ACary, ClintCary, ClintFoster, Richard S and Foster, Richard S
Urologic Oncology: Seminars and Original Investigations, 2019-Jan-07. | Journal Article
 
Cylindrical illumination with angular coupling for whole-prostate photoacoustic tomography
Bungart, BrittaniBungart, BrittaniCao, YingchunCao, YingchunYang-Tran, TiffanyYang-Tran, TiffanyGorsky, SeanGorsky, SeanLan, LuLan, LuRoblyer, DarrenRoblyer, DarrenKoch, Michael OKoch, Michael OCheng, LiangCheng, LiangMasterson, TimothyMasterson, TimothyCheng, Ji-Xin and Cheng, Ji-Xin
Biomedical optics express, vol. 10, (no. 3), pp. 1419, 2019-Mar-01. | Journal Article
 
Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline
Stephenson, AndrewStephenson, AndrewEggener, Scott EEggener, Scott EBass, Eric BBass, Eric BChelnick, David MChelnick, David MDaneshmand, SiamakDaneshmand, SiamakFeldman, DarrenFeldman, DarrenGilligan, TimothyGilligan, TimothyKaram, Jose AKaram, Jose ALeibovich, BradleyLeibovich, BradleyLiauw, Stanley LLiauw, Stanley LMasterson, Timothy AMasterson, Timothy AMeeks, Joshua JMeeks, Joshua JPierorazio, Phillip MPierorazio, Phillip MSharma, RituSharma, RituSheinfeld, Joel and Sheinfeld, Joel
The Journal of urology, vol. 202, (no. 2), pp. 281, 2019-08-00. | Journal Article
 
Editorial Comment
Masterson, Timothy A and Ramasamy, Ranjith
Journal of Urology, vol. 201, (no. 4), pp. 782, 2019-04-00. | Journal Article
 
MP38-02 UNDERSTANDING THE EFFECT OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF BLADDER CANCER WITH SQUAMOUS CELL HISTOLOGIC VARIANT
Speir, RyanSpeir, RyanSpeir, RyanCalaway, AdamCalaway, AdamCalaway, AdamBarboza, MarceloBarboza, MarceloBarboza, MarceloBihrle, RichardBihrle, RichardBihrle, RichardMasterson, TimothyMasterson, TimothyMasterson, TimothyKoch, MichaelKoch, MichaelKoch, MichaelCheng, LiangCheng, LiangCheng, LiangCary, ClintCary, ClintCary, ClintKaimakliotis, HristosKaimakliotis, Hristos and Kaimakliotis, Hristos
Journal of Urology, vol. 201, (no. Supplement 4), 2019-04-00. | Journal Article
 
MP49-02 ONCOLOGIC OUTCOMES FOLLOWING SURGICAL MANAGEMENT OF CLINICAL STAGE II SEX CORD STROMAL TUMORS
Calaway, AdamCalaway, AdamTachibana, IsamuTachibana, IsamuFoster, RichardFoster, RichardMasterson, TimothyMasterson, TimothyCary, Clint and Cary, Clint
Journal of Urology, vol. 201, (no. Supplement 4), 2019-04-00. | Journal Article
 
MP49-03 DOES SCHEDULED ALVIMOPAN, ACETAMINOPHEN AND GABAPENTIN IMPROVE SHORT-TERM CLINICAL OUTCOMES AFTER RETROPERITONEAL LYMPH NODE DISSECTION?: A PILOT STUDY
Calaway, AdamCalaway, AdamFoster, RichardFoster, RichardTong, YanTong, YanBihrle, RichardBihrle, RichardMasterson, TimothyMasterson, TimothyCary, Clint and Cary, Clint
Journal of Urology, vol. 201, (no. Supplement 4), 2019-04-00. | Journal Article
 
Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors
Calaway, Adam CCalaway, Adam CCalaway, Adam CTachibana, IsamuTachibana, IsamuTachibana, IsamuMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AFoster, Richard SFoster, Richard SFoster, Richard SEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HCary, ClintCary, Clint and Cary, Clint
Urology, vol. 127, pp. 79, May 2019. | Journal Article
 
PD03-02 UNDERSTANDING THE EFFECTIVENESS OF LYMPHADENECTOMY IN NODE ONLY RECURRENCES AFTER NEPHRECTOMY FOR KIDNEY CANCER
Panizzutti Barboza, MarceloPanizzutti Barboza, MarceloPanizzutti Barboza, MarceloPanizzutti Barboza, MarceloSpeir, RyanSpeir, RyanSpeir, RyanSpeir, RyanCalaway, AdamCalaway, AdamCalaway, AdamCalaway, AdamFoster, RichardFoster, RichardFoster, RichardFoster, RichardKaimakliotis, HristosKaimakliotis, HristosKaimakliotis, HristosKaimakliotis, HristosMasterson, TimothyMasterson, TimothyMasterson, TimothyMasterson, TimothyBoris, RonaldBoris, RonaldBoris, RonaldBoris, RonaldCary, ClintCary, ClintCary, Clint and Cary, Clint
Journal of Urology, vol. 201, (no. Supplement 4), 2019-04-00. | Journal Article
 
PD56-01 LONG-TERM ONCOLOGIC OUTCOMES AFTER PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION: MINIMIZING THE NEED FOR ADJUVANT CHEMOTHERAPY
Douglawi, AntoinDouglawi, AntoinCalaway, AdamCalaway, AdamTachibana, IsamuTachibana, IsamuBarboza, MarceloBarboza, MarceloMasterson, TimothyMasterson, TimothyFoster, RichardFoster, RichardCary, Clint and Cary, Clint
Journal of Urology, vol. 201, (no. Supplement 4), 2019-04-00. | Journal Article
 
PD56-02 IS THE PERCENTAGE OF TERATOMA IN THE ORCHIECTOMY SPECIMEN PREDICTIVE OF TERATOMA IN THE RETROPERITONEUM AT THE TIME OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION IN MEN WITH NON-SEMINOMATOUS GERM CELL TUMORS?
Calaway, AdamCalaway, AdamCalaway, AdamSpeir, RyanSpeir, RyanSpeir, RyanBarboza, MarceloBarboza, MarceloBarboza, MarceloDougwali, AntoinDougwali, AntoinDougwali, AntoinMasterson, TimothyMasterson, TimothyMasterson, TimothyFoster, RichardFoster, RichardFoster, RichardEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceCary, ClintCary, Clint and Cary, Clint
Journal of Urology, vol. 201, (no. Supplement 4), 2019-04-00. | Journal Article
 
Prognostic value of serum tumor marker (STM) rate of decline during high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT) for relapsed germ-cell tumors (rGCT)
Adra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KLiu, HaoLiu, HaoLiu, HaoLiu, HaoLiu, HaoLiu, HaoLiu, HaoAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AFoster, RichardFoster, RichardFoster, RichardFoster, RichardFoster, RichardFoster, RichardFoster, RichardAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence H and Einhorn, Lawrence H
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e16044, 2019-05-20. | Journal Article
 
Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton’s Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607–609
Calaway, Adam CCalaway, Adam CCalaway, Adam CEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AFoster, Richard SFoster, Richard SFoster, Richard SCary, ClintCary, Clint and Cary, Clint
European Urology, vol. 76, (no. 5), pp. e141, 2019-11-00. | Journal Article